'Pandemic Medicine: Why the Global Innovation System is Broken, and How We Can Fix It' Wins Global Health Best Book Award
Retrieved on:
Tuesday, April 5, 2022
Medicine, Health, Global Health, Infection, Prize, Economics, Therapy, Big Pharma, Center for Effective Global Action, National, Growth, Entrepreneurship, Stanford University Press, Vaccine, United States House Financial Services Subcommittee on National Security, International Development and Monetary Policy, Global health, Epidemic, Political economy, Environmental change, Global Research, Cancer, International Studies Association, Innovation, World Trade Organization, Andrew Price-Smith, Technology, Association, Lynne Rienner Publishers, COVID-19, GLOBE, University of Southern California academics, DePaul University, Science, Colorado College, Policy, Economic development, Development, ISA, Politics, World, University, History, Pharmaceutical industry, Management
Ibata-Arens was presented the award at the ISA's annual meeting on March 31 in Nashville, Tennessee.
Key Points:
- Ibata-Arens was presented the award at the ISA's annual meeting on March 31 in Nashville, Tennessee.
- The book explains why the wildly profitable, modern, Big Pharma industry and the restrictive global intellectual property rights regime it has created, backed by the World Trade Organization, pose a problem for human health today.
- The author shows how drug discoveries led by international networks of experimenters and social entrepreneurs are producing new and accessible healing medicines through "open innovation sandboxes."
- Such public-private partnerships are leading a transformation in bringing curative drug discoveries to humanity.